var data={"title":"Pathogenesis, clinical features, and diagnosis of erythema multiforme","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Pathogenesis, clinical features, and diagnosis of erythema multiforme</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/contributors\" class=\"contributor contributor_credentials\">David A Wetter, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/contributors\" class=\"contributor contributor_credentials\">Jeffrey Callen, MD, FACP, FAAD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/contributors\" class=\"contributor contributor_credentials\">Abena O Ofori, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Nov 15, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Erythema multiforme (EM) is an acute, immune-mediated condition characterized by the appearance of distinctive target-like lesions on the skin. These lesions are often accompanied by erosions or bullae involving the oral, genital, <span class=\"nowrap\">and/or</span> ocular mucosae. Erythema multiforme major is the term used to describe EM with mucosal involvement; erythema multiforme minor refers to EM without mucosal disease.</p><p>A variety of factors have been implicated in the pathogenesis of EM. The disorder is most commonly induced by infection, with herpes simplex virus being the most frequent precipitator. The clinical course of EM is usually self-limited, resolving within weeks without significant sequelae. However, in a minority of cases, the disease recurs frequently over the course of years.</p><p>Similarities in clinical and histopathologic findings have led to controversy over the distinction between EM and Stevens-Johnson syndrome (SJS), an often drug-induced disorder that may present with cutaneous targetoid lesions and mucosal erosions. However, there is suggestive evidence that EM with mucous membrane involvement and SJS are different diseases with distinct causes [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/1\" class=\"abstract_t\">1</a>]. The term erythema multiforme major should <strong>not</strong> be used to refer to SJS. &#160;</p><p>The epidemiology, pathogenesis, clinical features, evaluation, and diagnosis of acute and recurrent EM will be reviewed here. The treatment of EM and similar issues related to SJS are discussed separately. (See <a href=\"topic.htm?path=treatment-of-erythema-multiforme\" class=\"medical medical_review\">&quot;Treatment of erythema multiforme&quot;</a> and <a href=\"topic.htm?path=stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The annual incidence of erythema multiforme (EM) is unknown, although it is estimated to be far less than 1 percent [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/2\" class=\"abstract_t\">2</a>]. EM most frequently occurs in young adults between the ages of 20 and 40 and exhibits a slight male predominance. Children and older adults can also be affected [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/2,3\" class=\"abstract_t\">2,3</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">ETIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Many factors, including infections, medications, malignancy, autoimmune disease, immunizations, radiation, sarcoidosis, and menstruation have been linked to the development of erythema multiforme (EM) [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/2\" class=\"abstract_t\">2</a>]. Infections (viral, bacterial, or fungal) account for approximately 90 percent of cases, with herpes simplex virus (HSV) as the most commonly identified precipitant (<a href=\"image.htm?imageKey=DERM%2F64893\" class=\"graphic graphic_table graphicRef64893 \">table 1</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/2,4-6\" class=\"abstract_t\">2,4-6</a>]. Mycoplasma pneumoniae infection is another important cause of EM, particularly in children [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/2,7\" class=\"abstract_t\">2,7</a>].</p><p>It has been estimated that drugs induce EM in less than 10 percent of cases [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/4\" class=\"abstract_t\">4</a>], although higher rates of drug-induced EM (particularly penicillin-related EM) have been reported in children [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/8\" class=\"abstract_t\">8</a>]. A wide variety of medications have been associated with the eruption [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/2\" class=\"abstract_t\">2</a>]. The most common precipitators appear to be nonsteroidal anti-inflammatory drugs, sulfonamides, antiepileptics, and antibiotics (<a href=\"image.htm?imageKey=DERM%2F64893\" class=\"graphic graphic_table graphicRef64893 \">table 1</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/4\" class=\"abstract_t\">4</a>]. Of note, interpretation of the literature on drug-induced EM is complicated by confusion regarding the nosology of EM as compared with Stevens-Johnson syndrome and other conditions with target lesions. In an analysis of 37 published cases of drug-induced EM, 24 (65 percent) did not meet clinical criteria for EM [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/9,10\" class=\"abstract_t\">9,10</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Much of the available data on the pathogenesis of this disorder have been derived from studies investigating HSV-associated erythema multiforme (EM). The development of EM secondary to HSV infection is thought to involve a cell-mediated immune process directed against viral antigens deposited in lesional skin [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/11\" class=\"abstract_t\">11</a>]. The detection of HSV DNA in skin biopsy specimens from patients with EM supports this theory [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/11-16\" class=\"abstract_t\">11-16</a>].</p><p>The following mechanism has been proposed for the development of mucocutaneous lesions in the setting of HSV infection [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/17,18\" class=\"abstract_t\">17,18</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Virus released into the blood during reactivation of HSV infection is phagocytosed by circulating peripheral blood mononuclear cells, particularly Langerhans cells.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Langerhans cells containing HSV travel to the epidermis, where they transfer viral DNA fragments to epidermal keratinocytes. The migration of Langerhans cells to the epidermis is facilitated by virus-induced upregulation of E-cadherin expression on Langerhans cells and the presence of adhesion molecules on microvascular endothelial cells.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Expression of HSV genes in the skin leads to the recruitment of HSV-specific CD4+ Th1 cells that produce interferon (IFN) gamma in response to viral antigens.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The release of IFN-gamma initiates an inflammatory cascade that promotes the lysis of HSV-infected keratinocytes and the recruitment of autoreactive T-cells. These events lead to the epidermal damage and the inflammatory infiltrate that characterize cutaneous lesions of EM.</p><p/><p>It is unclear whether a similar pathway is responsible for the development of EM related to other inciting agents. In drug-induced EM, the presence of tumor necrosis factor (TNF) alpha rather than IFN-gamma correlates with the development of skin lesions [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/18\" class=\"abstract_t\">18</a>]. However, EM has occurred in the setting of TNF-alpha inhibitor therapy [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/19\" class=\"abstract_t\">19</a>].</p><p>EM does not occur in most people infected with HSV, and does not appear with every recurrence of HSV infection among individuals with a history of HSV-associated EM [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/20\" class=\"abstract_t\">20</a>]. The reason for this is unknown. It is postulated that a variety of factors may influence the development of EM, such as the presence of a key peripheral blood mononuclear cell subset, differences in the processing of viral DNA by phagocytic cells, variation in the specific viral proteins expressed in the skin, or the presence of other factors that affect the development of the autoreactive immune response [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/17,18\" class=\"abstract_t\">17,18</a>].</p><p>Genetic susceptibility may play a role in the preferential development of EM. In a study of 35 patients with EM and 80 controls, the HLA-DQB1*0301 allele was detected more frequently in patients with erythema multiforme than in the control population (66 versus 31 percent, respectively) [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/21\" class=\"abstract_t\">21</a>]. The strongest association with the allele was found among patients with herpes-associated EM [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/21\" class=\"abstract_t\">21</a>]. Associations with HLA types Aw33, DRw53, B15(62), B35, and DQ3 have also been reported; however, the relationship of Aw33 and DQ3 to EM has been questioned [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/22\" class=\"abstract_t\">22</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span></p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Cutaneous features</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The term &quot;multiforme&quot; describes the myriad clinical manifestations that may be observed. Though most lesions appear similar in a particular patient at a given time, the morphology of erythema multiforme (EM) lesions may vary between patients and also may evolve over the course of the disease in a single patient [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/2,23\" class=\"abstract_t\">2,23</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Appearance &ndash;</strong> Target lesions are the hallmark of the disorder, although they may not always be present. Initial lesions may begin as round erythematous papules that evolve into classic target lesions [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/3\" class=\"abstract_t\">3</a>]. Typical target lesions consist of three components: a dusky central area or blister, a dark red inflammatory zone surrounded by a pale ring of edema, and an erythematous halo on the extreme periphery of the lesion (<a href=\"image.htm?imageKey=DERM%2F68640\" class=\"graphic graphic_picture graphicRef68640 \">picture 1</a> and <a href=\"image.htm?imageKey=DERM%2F79955\" class=\"graphic graphic_picture graphicRef79955 \">picture 2</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/3,23\" class=\"abstract_t\">3,23</a>].</p><p/><p class=\"bulletIndent1\">Atypical target lesions may also occur in patients with EM. These manifest as raised, edematous, palpable lesions with only two zones of color change <span class=\"nowrap\">and/or</span> a poorly defined border (<a href=\"image.htm?imageKey=DERM%2F79955\" class=\"graphic graphic_picture graphicRef79955 \">picture 2</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/9\" class=\"abstract_t\">9</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Distribution &ndash;</strong> Cutaneous lesions most commonly appear in a symmetrical distribution on the extensor surfaces of the acral extremities, and subsequently spread in a centripetal manner (<a href=\"image.htm?imageKey=DERM%2F62370%7EDERM%2F72055%7EDERM%2F65570%7EDERM%2F80715%7EDERM%2F57894%7EDERM%2F54232\" class=\"graphic graphic_picture graphicRef62370 graphicRef72055 graphicRef65570 graphicRef80715 graphicRef57894 graphicRef54232 \">picture 3A-F</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/2\" class=\"abstract_t\">2</a>]. The face, neck, palms, soles, flexural surfaces of the extremities, <span class=\"nowrap\">and/or</span> trunk may also be involved [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/2,3\" class=\"abstract_t\">2,3</a>]. Although cutaneous lesions are usually asymptomatic, some patients may experience itching and burning [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/2\" class=\"abstract_t\">2</a>].</p><p/><p>EM may also occur at sites of physical trauma and sunburn, thus displaying the isomorphic (Koebner) phenomenon [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/2,3\" class=\"abstract_t\">2,3</a>]. Other features that may be observed in EM include erythema and swelling of the nail folds and clusters of lesions on and around the elbows and knees (<a href=\"image.htm?imageKey=DERM%2F76649\" class=\"graphic graphic_picture graphicRef76649 \">picture 4</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/3\" class=\"abstract_t\">3</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Mucous membrane involvement</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mucous membrane involvement usually occurs in association with cutaneous lesions. Infrequently, EM may present with mucous membrane lesions alone [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/24\" class=\"abstract_t\">24</a>]. Lesions can involve the oral, ocular, <span class=\"nowrap\">and/or</span> genital mucosa, and commonly manifest as diffuse areas of mucosal erythema, painful erosions, <span class=\"nowrap\">and/or</span> bullae.</p><p>Oral involvement occurs most commonly, and can affect up to 70 percent of patients with EM (<a href=\"image.htm?imageKey=DERM%2F68153%7EDERM%2F58969\" class=\"graphic graphic_picture graphicRef68153 graphicRef58969 \">picture 5A-B</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/20,25,26\" class=\"abstract_t\">20,25,26</a>]. Lesions tend to affect the vermilion lip and mucosal surfaces, including the buccal mucosa, labial mucosa, non-attached gingiva, and tongue [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/27-29\" class=\"abstract_t\">27-29</a>]. Rarely, involvement can extend to the pharynx and upper respiratory tract [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/2\" class=\"abstract_t\">2</a>].</p><p>Mucosal lesions in other sites are less common; in one series of 65 patients with recurrent EM, 25 percent had genital lesions and 17 percent had ocular involvement (<a href=\"image.htm?imageKey=DERM%2F75314\" class=\"graphic graphic_picture graphicRef75314 \">picture 6</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/20\" class=\"abstract_t\">20</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Systemic symptoms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Prodromal symptoms (eg, fever, malaise, myalgias) are uncommon in mild cases of EM but can be seen in cases with significant mucosal involvement [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/2\" class=\"abstract_t\">2</a>]. Cough and respiratory symptoms may be present in patients with EM related to M. pneumoniae infection.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Course</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>EM lesions usually appear over the course of three to five days and resolve within approximately two weeks. [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/3\" class=\"abstract_t\">3</a>]. Although the skin lesions do not scar, postinflammatory hyperpigmentation may remain for months after resolution, particularly in patients with dark skin.</p><p>Infrequently, ocular involvement can lead to keratitis, conjunctival scarring, and visual impairment [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/2,3\" class=\"abstract_t\">2,3</a>]. Esophagitis and upper airway involvement leading to pneumonia have rarely been described [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/2,3\" class=\"abstract_t\">2,3</a>].</p><p>In HSV-associated EM, the eruption usually occurs 2 to 17 days after an episode of herpes simplex (mean interval is eight days) [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/20\" class=\"abstract_t\">20</a>]. EM can also be induced by asymptomatic subclinical recurrences of HSV infection [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/20,23\" class=\"abstract_t\">20,23</a>]. (See <a href=\"#H11\" class=\"local\">'Recurrent erythema multiforme'</a> below.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Laboratory findings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Laboratory findings are not specific for EM. In severe cases, elevations of the erythrocyte sedimentation rate, white blood cell count, and liver enzymes may be detected [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/2,3,23\" class=\"abstract_t\">2,3,23</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">RECURRENT ERYTHEMA MULTIFORME</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A subset of patients with erythema multiforme (EM) experience frequent episodes over many years leading to substantial morbidity, a condition termed recurrent EM. Studies of patients with this disorder found average rates of recurrence of six episodes per year, with mean durations of disease ranging from 6 to 10 years [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/20,25\" class=\"abstract_t\">20,25</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Etiology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Similar to isolated episodes of EM, recurrent EM has been linked to a variety of inciting factors. Recurrent EM can occur in association with HSV infection, and some studies have estimated that 61 to 100 percent of cases are due to HSV [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/20,24-26,30-32\" class=\"abstract_t\">20,24-26,30-32</a>]. However, in one series of 48 patients with recurrent disease, a clear relationship to HSV was detected in only 23 percent of subjects [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/25\" class=\"abstract_t\">25</a>]. Other conditions reported to occur in association with recurrent EM have included repeated M. pneumoniae infections [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/25,33\" class=\"abstract_t\">25,33</a>], hepatitis C [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/25,34,35\" class=\"abstract_t\">25,34,35</a>], vulvovaginal candidiasis [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/25\" class=\"abstract_t\">25</a>], menses [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/20\" class=\"abstract_t\">20</a>], complex aphthosis [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/25\" class=\"abstract_t\">25</a>], polymorphic light eruption [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/36\" class=\"abstract_t\">36</a>], and ingestion of benzoic acid, a preservative in food [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/32\" class=\"abstract_t\">32</a>].</p><p>The cause of recurrent EM may be unclear in up to 60 percent of patients [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/25\" class=\"abstract_t\">25</a>], and there is evidence that some cases classified as idiopathic EM may be related to subclinical HSV infection [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/11,14\" class=\"abstract_t\">11,14</a>]. One study utilizing polymerase chain reaction (PCR) on lesional skin biopsy specimens from patients with recurrent EM found that HSV DNA was detected in 6 out of 12 specimens from patients with idiopathic recurrent disease [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/14\" class=\"abstract_t\">14</a>]. Another study found similar results; HSV DNA was detected in three out of five patients with idiopathic recurrent EM [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/11\" class=\"abstract_t\">11</a>].</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h1\">PERSISTENT ERYTHEMA MULTIFORME</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Persistent erythema multiforme (EM) is a rare variant of EM characterized by the uninterrupted occurrence of typical and atypical EM lesions [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/37-40\" class=\"abstract_t\">37-40</a>]. Cutaneous lesions are often widespread and papulonecrotic or bullous; mucosal lesions may or may not be present. Laboratory abnormalities including hypocomplementemia and circulating immune complexes also can occur, but are not found in all affected patients [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/40\" class=\"abstract_t\">40</a>].</p><p>Persistent EM has been reported in association with viral infections such as herpes simplex virus (HSV), Epstein-Barr virus (EBV), hepatitis C, and influenza, as well as inflammatory bowel disease and malignancy [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/39\" class=\"abstract_t\">39</a>]. The disorder may continue for longer than one year without therapy.</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">HISTOPATHOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Skin biopsy can assist with the exclusion of other disorders that may present with clinical features that resemble erythema multiforme (EM). (See <a href=\"#H20\" class=\"local\">'Differential diagnosis'</a> below.)</p><p>Pathologic findings in EM typically include basal cell vacuolar degeneration, scattered necrotic keratinocytes, and lymphocyte exocytosis (<a href=\"image.htm?imageKey=DERM%2F56873\" class=\"graphic graphic_picture graphicRef56873 \">picture 7</a>). A dense superficial dermal lymphohistiocytic infiltrate surrounding blood vessels and the dermoepidermal junction is also present [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/41-43\" class=\"abstract_t\">41-43</a>]. Papillary dermal edema and red blood cell extravasation may be evident, particularly in early lesions [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/42,43\" class=\"abstract_t\">42,43</a>]. Subepidermal clefting and vesiculation, the results of extensive basal cell vacuolar degeneration, are present in some specimens [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/43\" class=\"abstract_t\">43</a>].</p><p>The site of the biopsy within an EM lesion can influence the histopathologic findings. While specimens from the dusky central portions of lesions may reveal subepidermal separation with necrotic keratinocytes, biopsies from the peripheral portions often show predominantly dermal changes, such as papillary dermal edema, vascular dilation, and a perivascular mononuclear cell infiltrate [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/41\" class=\"abstract_t\">41</a>].</p><p>Mucous membrane lesions in EM demonstrate similar histologic features to those observed in cutaneous lesions. Additionally, more prominent spongiosis and intracellular edema and vesiculation may be present [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/43\" class=\"abstract_t\">43</a>].</p><p>Findings on direct immunofluorescence microscopy are usually non-specific. One study found granular deposits of C3 and IgM at the dermoepidermal junction and around superficial dermal blood vessels [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/41\" class=\"abstract_t\">41</a>]. In addition, fibrin was detected around dermal blood vessels and in a band-like distribution at the dermoepidermal junction in regions of necrosis or blister formation.</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h1\">EVALUATION AND DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The history of the eruption and clinical findings provide the most important information for the diagnosis of erythema multiforme (EM). Patients should be asked about signs or symptoms of HSV, M. pneumoniae, or other infections, as well as new medications and systemic symptoms. Skin biopsy and laboratory studies may help to confirm the diagnosis when necessary and may assist with determining the inciting factor in cases consistent with EM.</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h2\">Biopsy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>When the diagnosis is in question, a skin biopsy should be performed to exclude other disorders. If the differential diagnosis includes autoimmune bullous diseases such as pemphigus or pemphigoid, direct immunofluorescence studies should be performed on a second biopsy specimen taken from unaffected skin adjacent to a lesion. Blood tests for indirect immunofluorescence may also be useful for the diagnosis of autoimmune blistering disease. (See <a href=\"#H14\" class=\"local\">'Histopathology'</a> above and <a href=\"#H20\" class=\"local\">'Differential diagnosis'</a> below and <a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-pemphigus\" class=\"medical medical_review\">&quot;Pathogenesis, clinical manifestations, and diagnosis of pemphigus&quot;</a> and <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-bullous-pemphigoid-and-mucous-membrane-pemphigoid\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">HSV infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>HSV is the most common cause of erythema multiforme, and the possibility of HSV-induced disease should be considered in all patients. A careful history and clinical exam should be performed to identify signs or symptoms of a recent HSV eruption. If lesions concerning for active HSV infection remain, sampling of lesions for direct fluorescent antibody, viral culture, Tzanck smear, or PCR studies are useful to confirm the presence of the virus. (See <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-genital-herpes-simplex-virus-infection\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-herpes-simplex-virus-type-1-infection\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of herpes simplex virus type 1 infection&quot;</a>.)</p><p>In patients with recurrent disease for whom history and clinical examination do not support a clear relationship to HSV, serologic tests should be performed. Serologic testing for HSV will help to exclude HSV-associated EM when negative; however, antibody titers are not useful for detecting episodes of recurrent disease. If a skin biopsy is performed, molecular testing (PCR or in-situ hybridization) for HSV on skin biopsy specimens can be utilized to confirm a diagnosis of HSV-associated EM.</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h2\">M. pneumoniae infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In patients who present with respiratory symptoms, serologic tests for M. pneumoniae can help to confirm a diagnosis of M. pneumoniae-related EM. PCR techniques have also been used in the diagnosis of M. pneumoniae infections. (See <a href=\"topic.htm?path=mycoplasma-pneumoniae-infection-in-adults#H16\" class=\"medical medical_review\">&quot;Mycoplasma pneumoniae infection in adults&quot;, section on 'Diagnosis'</a> and <a href=\"topic.htm?path=mycoplasma-pneumoniae-infection-in-children#H15\" class=\"medical medical_review\">&quot;Mycoplasma pneumoniae infection in children&quot;, section on 'Diagnosis'</a>.)</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Other tests</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with severe EM in whom oral intake may be compromised should be assessed for fluid and electrolyte abnormalities. As mentioned above, the erythrocyte sedimentation rate, white blood cell count, and hepatic transaminases may be elevated in patients with severe EM. Cutaneous lesions with signs concerning for secondary infection should be cultured and treated as appropriate.</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The identification of typical target lesions with three color zones is a hallmark for the diagnosis of erythema multiforme (EM). However, classic target lesions may be few in number, and a variety of disorders may present with mucocutaneous lesions that resemble the other manifestations of EM [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/4,44\" class=\"abstract_t\">4,44</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Urticaria </strong>&ndash; Urticaria presents as erythematous, edematous plaques that lack the central dusky, bullous, or crusted zones that are typical for lesions of EM. Individual lesions are transient, lasting less than 24 hours. Unlike EM, in which all lesions appear within the first 72 hours of the disorder, new lesions of urticaria continuously appear. Histopathologic findings can help differentiate urticaria from EM when necessary. (See <a href=\"topic.htm?path=new-onset-urticaria\" class=\"medical medical_review\">&quot;New-onset urticaria&quot;</a>.)</p><p/><p class=\"bulletIndent1\">Urticaria multiforme is a morphologic subtype of urticaria in children that presents with annular and polycyclic lesions with a dusky, ecchymotic central portion [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/45,46\" class=\"abstract_t\">45,46</a>], thus simulating EM. In contrast to EM (and similar to other subtypes of urticaria), individual lesions of urticaria multiforme last less than 24 hours. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Stevens-Johnson syndrome </strong>&ndash; Both Stevens-Johnson syndrome and EM may present with mucosal erosions and atypical target lesions on the skin. The atypical target lesions of Stevens-Johnson syndrome tend to be macular, rather than the papular lesions associated with EM. Unlike EM, medication is the most frequent cause of Stevens-Johnson syndrome. (See <a href=\"topic.htm?path=stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Fixed drug eruption </strong>&ndash; Fixed drug eruptions are characterized by single or multiple, dusky erythematous plaques with or without central bullae or necrosis. In some cases, the clinical and histologic features of a generalized fixed drug eruption are difficult to differentiate from EM. Fixed drug eruption typically has fewer lesions present at the time of first outbreak [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/4\" class=\"abstract_t\">4</a>]. A thorough medication history also may assist with the diagnosis. (See <a href=\"topic.htm?path=fixed-drug-eruption\" class=\"medical medical_review\">&quot;Fixed drug eruption&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Pemphigoid </strong>&ndash; Bullous pemphigoid is a chronic autoimmune blistering disorder that can present with urticarial, erythematous plaques and tense bullae, with or without mucosal involvement. Typical target lesions and the dusky erythema associated with epidermal necrosis in EM are extremely rare. A biopsy taken directly from a lesion for routine processing and a second biopsy taken from adjacent skin for direct immunofluorescence studies can distinguish this disorder from EM. Indirect immunofluorescence studies can also aid in the distinction between bullous pemphigoid and EM. (See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-bullous-pemphigoid-and-mucous-membrane-pemphigoid\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid&quot;</a>.) &#160;</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Paraneoplastic pemphigus </strong>&ndash; Paraneoplastic pemphigus can present with polymorphous skin lesions (including lesions reminiscent of EM) and mucosal erosions. Skin biopsy, direct immunofluorescence microscopy, and indirect immunofluorescence studies aid in the differentiation of paraneoplastic pemphigus from EM. (See <a href=\"topic.htm?path=paraneoplastic-pemphigus\" class=\"medical medical_review\">&quot;Paraneoplastic pemphigus&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Sweet syndrome </strong>&ndash; Sweet syndrome (also known as acute febrile neutrophilic dermatosis) may present with edematous, erythematous plaques reminiscent of EM. Routine histopathology demonstrating a predominantly neutrophilic infiltrate easily distinguishes Sweet syndrome from EM. (See <a href=\"topic.htm?path=sweet-syndrome-acute-febrile-neutrophilic-dermatosis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Sweet syndrome (acute febrile neutrophilic dermatosis): Pathogenesis, clinical manifestations, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Rowell syndrome </strong>&ndash; Rowell syndrome describes the occurrence of EM-like lesions in patients with cutaneous lesions of lupus erythematosus. These patients frequently have a positive antinuclear antibody (speckled pattern) [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/47,48\" class=\"abstract_t\">47,48</a>]. Histopathologic and serologic findings can help differentiate this process from EM.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Polymorphous light eruption </strong>&ndash; Pediatric cases of HSV-induced EM that clinically and histopathologically resemble the photodistributed erythematous papules, plaques, and bullae of polymorphous light eruption and juvenile spring eruption have been reported [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/49,50\" class=\"abstract_t\">49,50</a>]. A history of herpetic lesions preceding the eruption are clues to the diagnosis of EM. (See <a href=\"topic.htm?path=polymorphous-light-eruption\" class=\"medical medical_review\">&quot;Polymorphous light eruption&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Cutaneous small vessel vasculitis </strong>&ndash; Cutaneous small vessel vasculitis can present with urticarial lesions (eg, urticarial vasculitis) or targetoid lesions (eg, IgA vasculitis) that may appear similar to EM [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/51,52\" class=\"abstract_t\">51,52</a>]. Routine histopathology demonstrating leukocytoclastic vasculitis, as well as direct immunofluorescence studies, can readily differentiate this condition from EM. (See <a href=\"topic.htm?path=urticarial-vasculitis\" class=\"medical medical_review\">&quot;Urticarial vasculitis&quot;</a> and <a href=\"topic.htm?path=iga-vasculitis-henoch-schonlein-purpura-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;IgA vasculitis (Henoch-Sch&ouml;nlein purpura): Clinical manifestations and diagnosis&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H21\"><span class=\"h2\">Oral erythema multiforme</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of patients with oral erythema multiforme (EM) includes paraneoplastic pemphigus, pemphigus vulgaris, mucous membrane pemphigoid, oral lichen planus, and complex aphthosis, all of which can present with oral erosions [<a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/27,28\" class=\"abstract_t\">27,28</a>]. In contrast to these chronic conditions, the course of EM is typically self-limited. However, the possibility of these other disorders should be considered in patients with frequently recurring disease. Biopsies with direct immunofluorescence studies are useful for establishing the diagnosis. Indirect immunofluorescence studies on serum can also be performed to evaluate for specific autoimmune blistering diseases. (See <a href=\"#H14\" class=\"local\">'Histopathology'</a> above and <a href=\"#H20\" class=\"local\">'Differential diagnosis'</a> above and <a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-pemphigus\" class=\"medical medical_review\">&quot;Pathogenesis, clinical manifestations, and diagnosis of pemphigus&quot;</a> and <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-bullous-pemphigoid-and-mucous-membrane-pemphigoid\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid&quot;</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topic (see <a href=\"topic.htm?path=erythema-multiforme-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Erythema multiforme (The Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H22\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Erythema multiforme (EM) is an uncommon, immune-mediated disorder that presents with cutaneous <span class=\"nowrap\">and/or</span> mucosal lesions. EM most frequently affects young adults, but may occur at any age. (See <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>EM can be induced by a variety of factors. Infections are the most common causes of EM; herpes simplex virus is the most frequent etiologic agent. Less than 10 percent of cases of EM are associated with medications. (See <a href=\"#H3\" class=\"local\">'Etiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The pathogenesis of HSV-induced EM is thought to involve a cell-mediated immune process directed against viral antigens deposited in lesional skin. Genetic susceptibility may also play a role in the development of the disorder. (See <a href=\"#H4\" class=\"local\">'Pathogenesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The target lesion is a characteristic finding in EM, although not present in all patients. Target lesions consist of three concentric zones of color change: a central dusky or blistered area, a dark red inflammatory zone surrounded by a pale ring of edema, and a peripheral erythematous halo. (See <a href=\"#H6\" class=\"local\">'Cutaneous features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cutaneous lesions frequently begin on the extensor acral extremities, and may spread centripetally to other areas. Lesions are usually asymptomatic, although some patients may note pruritus or a burning sensation. EM may also involve mucosal surfaces, presenting as painful erythematous patches, erosions, or bullae. EM resolves in approximately two weeks. Some patients with EM may experience frequently recurring disease. (See <a href=\"#H5\" class=\"local\">'Clinical manifestations'</a> above and <a href=\"#H11\" class=\"local\">'Recurrent erythema multiforme'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of acute erythema multiforme typically is based upon the patient's history and clinical findings. When the diagnosis is uncertain, skin biopsies are useful for establishing the diagnosis. Direct immunofluorescence studies are usually indicated to exclude the possibility of autoimmune blistering disease. (See <a href=\"#H15\" class=\"local\">'Evaluation and diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>HSV infection is the most common cause of erythema multiforme, and the possibility of HSV-induced disease should be considered in all patients. Serologic testing is useful for excluding HSV-associated EM when negative. However, it cannot identify a recurrent episode of HSV infection. Where available, HSV detected in skin biopsy specimens can also be used to confirm HSV-induced disease. (See <a href=\"#H15\" class=\"local\">'Evaluation and diagnosis'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/1\" class=\"nounderline abstract_t\">Assier H, Bastuji-Garin S, Revuz J, Roujeau JC. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 1995; 131:539.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/2\" class=\"nounderline abstract_t\">Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 1983; 8:763.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/3\" class=\"nounderline abstract_t\">Huff JC. Erythema multiforme. Dermatol Clin 1985; 3:141.</a></li><li class=\"breakAll\">French LE, Prins C. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. In: Dermatology, Bolognia JL, Jorizzo JL, Rapini RP (Eds), Elsevier Limited, 2008. p.287.</li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/5\" class=\"nounderline abstract_t\">Weston WL, Brice SL, Jester JD, et al. Herpes simplex virus in childhood erythema multiforme. Pediatrics 1992; 89:32.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/6\" class=\"nounderline abstract_t\">Weston WL. Herpes-associated erythema multiforme. J Invest Dermatol 2005; 124:xv.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/7\" class=\"nounderline abstract_t\">Schalock PC, Dinulos JG, Pace N, et al. Erythema multiforme due to Mycoplasma pneumoniae infection in two children. Pediatr Dermatol 2006; 23:546.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/8\" class=\"nounderline abstract_t\">Keller N, Gilad O, Marom D, et al. Nonbullous Erythema Multiforme in Hospitalized Children: A 10-Year Survey. Pediatr Dermatol 2015; 32:701.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/9\" class=\"nounderline abstract_t\">Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129:92.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/10\" class=\"nounderline abstract_t\">Roujeau JC. Re-evaluation of 'drug-induced' erythema multiforme in the medical literature. Br J Dermatol 2016; 175:650.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/11\" class=\"nounderline abstract_t\">Brice SL, Krzemien D, Weston WL, Huff JC. Detection of herpes simplex virus DNA in cutaneous lesions of erythema multiforme. J Invest Dermatol 1989; 93:183.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/12\" class=\"nounderline abstract_t\">Brice SL, Leahy MA, Ong L, et al. Examination of non-involved skin, previously involved skin, and peripheral blood for herpes simplex virus DNA in patients with recurrent herpes-associated erythema multiforme. J Cutan Pathol 1994; 21:408.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/13\" class=\"nounderline abstract_t\">Miura S, Smith CC, Burnett JW, Aurelian L. Detection of viral DNA within skin of healed recurrent herpes simplex infection and erythema multiforme lesions. J Invest Dermatol 1992; 98:68.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/14\" class=\"nounderline abstract_t\">Ng PP, Sun YJ, Tan HH, Tan SH. Detection of herpes simplex virus genomic DNA in various subsets of Erythema multiforme by polymerase chain reaction. Dermatology 2003; 207:349.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/15\" class=\"nounderline abstract_t\">Darragh TM, Egbert BM, Berger TG, Yen TS. Identification of herpes simplex virus DNA in lesions of erythema multiforme by the polymerase chain reaction. J Am Acad Dermatol 1991; 24:23.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/16\" class=\"nounderline abstract_t\">Aslanzadeh J, Helm KF, Espy MJ, et al. Detection of HSV-specific DNA in biopsy tissue of patients with erythema multiforme by polymerase chain reaction. Br J Dermatol 1992; 126:19.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/17\" class=\"nounderline abstract_t\">Ono F, Sharma BK, Smith CC, et al. CD34+ cells in the peripheral blood transport herpes simplex virus DNA fragments to the skin of patients with erythema multiforme (HAEM). J Invest Dermatol 2005; 124:1215.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/18\" class=\"nounderline abstract_t\">Aurelian L, Ono F, Burnett J. Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): a viral disease with an autoimmune component. Dermatol Online J 2003; 9:1.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/19\" class=\"nounderline abstract_t\">Ahdout J, Haley JC, Chiu MW. Erythema multiforme during anti-tumor necrosis factor treatment for plaque psoriasis. J Am Acad Dermatol 2010; 62:874.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/20\" class=\"nounderline abstract_t\">Schofield JK, Tatnall FM, Leigh IM. Recurrent erythema multiforme: clinical features and treatment in a large series of patients. Br J Dermatol 1993; 128:542.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/21\" class=\"nounderline abstract_t\">Khalil I, Lepage V, Douay C, et al. HLA DQB1*0301 allele is involved in the susceptibility to erythema multiforme. J Invest Dermatol 1991; 97:697.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/22\" class=\"nounderline abstract_t\">Schofield JK, Tatnall FM, Brown J, et al. Recurrent erythema multiforme: tissue typing in a large series of patients. Br J Dermatol 1994; 131:532.</a></li><li class=\"breakAll\">Roujeau JC. Erythema multiforme. In: Fitzpatrick's Dermatology in General Medicine, Wolff K, Goldsmith LA, Katz SI, et al (Eds), McGraw-Hill Companies, Inc, 2008. p.343.</li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/24\" class=\"nounderline abstract_t\">Bean SF, Quezada RK. Recurrent oral erythema multiforme. Clinical experience with 11 patients. JAMA 1983; 249:2810.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/25\" class=\"nounderline abstract_t\">Wetter DA, Davis MD. Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007. J Am Acad Dermatol 2010; 62:45.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/26\" class=\"nounderline abstract_t\">Farthing PM, Maragou P, Coates M, et al. Characteristics of the oral lesions in patients with cutaneous recurrent erythema multiforme. J Oral Pathol Med 1995; 24:9.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/27\" class=\"nounderline abstract_t\">Ayangco L, Rogers RS 3rd. Oral manifestations of erythema multiforme. Dermatol Clin 2003; 21:195.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/28\" class=\"nounderline abstract_t\">Rogers RS 3rd. Pseudo-Beh&ccedil;et's disease. Dermatol Clin 2003; 21:49.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/29\" class=\"nounderline abstract_t\">Celentano A, Tovaru S, Yap T, et al. Oral erythema multiforme: trends and clinical findings of a large retrospective European case series. Oral Surg Oral Med Oral Pathol Oral Radiol 2015; 120:707.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/30\" class=\"nounderline abstract_t\">Huff JC, Weston WL. Recurrent erythema multiforme. Medicine (Baltimore) 1989; 68:133.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/31\" class=\"nounderline abstract_t\">Leigh IM, Mowbray JF, Levene GM, Sutherland S. Recurrent and continuous erythema multiforme--a clinical and immunological study. Clin Exp Dermatol 1985; 10:58.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/32\" class=\"nounderline abstract_t\">Lewis MA, Lamey PJ, Forsyth A, Gall J. Recurrent erythema multiforme: a possible role of foodstuffs. Br Dent J 1989; 166:371.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/33\" class=\"nounderline abstract_t\">Grosber M, Alexandre M, Poszepczynska-Guign&eacute; E, et al. Recurrent erythema multiforme in association with recurrent Mycoplasma pneumoniae infections. J Am Acad Dermatol 2007; 56:S118.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/34\" class=\"nounderline abstract_t\">Dumas V, Thieulent N, Souillet AL, et al. Recurrent erythema multiforme and chronic hepatitis C: efficacy of interferon alpha. Br J Dermatol 2000; 142:1248.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/35\" class=\"nounderline abstract_t\">Geraminejad P, Walling HW, Voigt MD, Stone MS. Severe erythema multiforme responding to interferon alfa. J Am Acad Dermatol 2006; 54:S18.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/36\" class=\"nounderline abstract_t\">Fraser-Andrews EA, Morris-Jones R, Novakovic L, Hawk JL. Erythema multiforme following polymorphic light eruption: a report of two cases. Clin Exp Dermatol 2005; 30:232.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/37\" class=\"nounderline abstract_t\">Drago F, Parodi A, Rebora A. Persistent erythema multiforme: report of two new cases and review of literature. J Am Acad Dermatol 1995; 33:366.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/38\" class=\"nounderline abstract_t\">Pavlovi&#263; MD, Karadagli&#263; DM, Kandolf LO, Mijuskovi&#263; ZP. Persistent erythema multiforme: a report of three cases. J Eur Acad Dermatol Venereol 2001; 15:54.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/39\" class=\"nounderline abstract_t\">Chen CW, Tsai TF, Chen YF, Hung CM. Persistent erythema multiforme treated with thalidomide. Am J Clin Dermatol 2008; 9:123.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/40\" class=\"nounderline abstract_t\">Wanner M, Pol-Rodriguez M, Hinds G, et al. Persistent erythema multiforme and CMV infection. J Drugs Dermatol 2007; 6:333.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/41\" class=\"nounderline abstract_t\">Howland WW, Golitz LE, Weston WL, Huff JC. Erythema multiforme: clinical, histopathologic, and immunologic study. J Am Acad Dermatol 1984; 10:438.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/42\" class=\"nounderline abstract_t\">Ackerman AB, Penneys NS, Clark WH. Erythema multiforme exudativum: distinctive pathological process. Br J Dermatol 1971; 84:554.</a></li><li class=\"breakAll\">McKee PH. Lichenoid and interface dermatoses. In: Pathology of the skin with clinical correlations, McKee PH, Calonje E, Granter SR (Eds), Elsevier Limited, Philadelphia, PA 2005. p.237.</li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/44\" class=\"nounderline abstract_t\">Weston JA, Weston WL. The overdiagnosis of erythema multiforme. Pediatrics 1992; 89:802.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/45\" class=\"nounderline abstract_t\">Mathur AN, Mathes EF. Urticaria mimickers in children. Dermatol Ther 2013; 26:467.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/46\" class=\"nounderline abstract_t\">Emer JJ, Bernardo SG, Kovalerchik O, Ahmad M. Urticaria multiforme. J Clin Aesthet Dermatol 2013; 6:34.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/47\" class=\"nounderline abstract_t\">Zeitouni NC, Funaro D, Cloutier RA, et al. Redefining Rowell's syndrome. Br J Dermatol 2000; 142:343.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/48\" class=\"nounderline abstract_t\">Lee A, Batra P, Furer V, et al. Rowell syndrome (systemic lupus erythematosus + erythema multiforme). Dermatol Online J 2009; 15:1.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/49\" class=\"nounderline abstract_t\">Wolf P, Soyer HP, Fink-Puches R, et al. Recurrent post-herpetic erythema multiforme mimicking polymorphic light and juvenile spring eruption: report of two cases in young boys. Br J Dermatol 1994; 131:364.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/50\" class=\"nounderline abstract_t\">P&eacute;rez-Carmona L, Va&ntilde;o-Galvan S, Carrillo-Gij&oacute;n R, Ja&eacute;n-Olasolo P. Photosensitive erythema multiforme presenting as juvenile spring eruption. Photodermatol Photoimmunol Photomed 2010; 26:53.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/51\" class=\"nounderline abstract_t\">Sokumbi O, Wetter DA. Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist. Int J Dermatol 2012; 51:889.</a></li><li><a href=\"https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme/abstract/52\" class=\"nounderline abstract_t\">Hughey LC. Approach to the hospitalized patient with targetoid lesions. Dermatol Ther 2011; 24:196.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 5559 Version 20.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H22\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">ETIOLOGY</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">PATHOGENESIS</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H6\" id=\"outline-link-H6\">Cutaneous features</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">Mucous membrane involvement</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Systemic symptoms</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Course</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Laboratory findings</a></li></ul></li><li><a href=\"#H11\" id=\"outline-link-H11\">RECURRENT ERYTHEMA MULTIFORME</a><ul><li><a href=\"#H12\" id=\"outline-link-H12\">Etiology</a></li></ul></li><li><a href=\"#H13\" id=\"outline-link-H13\">PERSISTENT ERYTHEMA MULTIFORME</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">HISTOPATHOLOGY</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">EVALUATION AND DIAGNOSIS</a><ul><li><a href=\"#H16\" id=\"outline-link-H16\">Biopsy</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">HSV infection</a></li><li><a href=\"#H18\" id=\"outline-link-H18\">M. pneumoniae infection</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">Other tests</a></li></ul></li><li><a href=\"#H20\" id=\"outline-link-H20\">DIFFERENTIAL DIAGNOSIS</a><ul><li><a href=\"#H21\" id=\"outline-link-H21\">Oral erythema multiforme</a></li></ul></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H24090305\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/5559|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/68640\" class=\"graphic graphic_picture\">- Erythema multiforme target</a></li><li><a href=\"image.htm?imageKey=DERM/79955\" class=\"graphic graphic_picture\">- Erythema multiforme target lesion</a></li><li><a href=\"image.htm?imageKey=DERM/62370\" class=\"graphic graphic_picture\">- Erythema multiforme acral</a></li><li><a href=\"image.htm?imageKey=DERM/72055\" class=\"graphic graphic_picture\">- Erythema multiforme arm</a></li><li><a href=\"image.htm?imageKey=DERM/65570\" class=\"graphic graphic_picture\">- Erythema multiforme face</a></li><li><a href=\"image.htm?imageKey=DERM/80715\" class=\"graphic graphic_picture\">- Erythema multiforme palm</a></li><li><a href=\"image.htm?imageKey=DERM/57894\" class=\"graphic graphic_picture\">- Erythema multiforme on extremity</a></li><li><a href=\"image.htm?imageKey=DERM/54232\" class=\"graphic graphic_picture\">- Erythema multiforme leg</a></li><li><a href=\"image.htm?imageKey=DERM/76649\" class=\"graphic graphic_picture\">- Erythema multiforme elbow</a></li><li><a href=\"image.htm?imageKey=DERM/68153\" class=\"graphic graphic_picture\">- Erythema multiforme lip</a></li><li><a href=\"image.htm?imageKey=DERM/58969\" class=\"graphic graphic_picture\">- Erythema multiforme tongue</a></li><li><a href=\"image.htm?imageKey=DERM/75314\" class=\"graphic graphic_picture\">- Erythema multiforme genital</a></li><li><a href=\"image.htm?imageKey=DERM/56873\" class=\"graphic graphic_picture\">- Erythema multiforme path</a></li></ul></li><li><div id=\"DERM/5559|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/64893\" class=\"graphic graphic_table\">- Erythema multiforme causes</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-bullous-pemphigoid-and-mucous-membrane-pemphigoid\" class=\"medical medical_review\">Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-herpes-simplex-virus-type-1-infection\" class=\"medical medical_review\">Clinical manifestations and diagnosis of herpes simplex virus type 1 infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-genital-herpes-simplex-virus-infection\" class=\"medical medical_review\">Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=fixed-drug-eruption\" class=\"medical medical_review\">Fixed drug eruption</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=iga-vasculitis-henoch-schonlein-purpura-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">IgA vasculitis (Henoch-Sch&ouml;nlein purpura): Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mycoplasma-pneumoniae-infection-in-adults\" class=\"medical medical_review\">Mycoplasma pneumoniae infection in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mycoplasma-pneumoniae-infection-in-children\" class=\"medical medical_review\">Mycoplasma pneumoniae infection in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=new-onset-urticaria\" class=\"medical medical_review\">New-onset urticaria</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=paraneoplastic-pemphigus\" class=\"medical medical_review\">Paraneoplastic pemphigus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-pemphigus\" class=\"medical medical_review\">Pathogenesis, clinical manifestations, and diagnosis of pemphigus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=erythema-multiforme-the-basics\" class=\"medical medical_basics\">Patient education: Erythema multiforme (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=polymorphous-light-eruption\" class=\"medical medical_review\">Polymorphous light eruption</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=sweet-syndrome-acute-febrile-neutrophilic-dermatosis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Sweet syndrome (acute febrile neutrophilic dermatosis): Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-erythema-multiforme\" class=\"medical medical_review\">Treatment of erythema multiforme</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=urticarial-vasculitis\" class=\"medical medical_review\">Urticarial vasculitis</a></li></ul></div></div>","javascript":null}